Share Price and Basic Stock Data
Last Updated: January 14, 2026, 8:38 pm
| PEG Ratio | 13.08 |
|---|
Analyst Insight & Comprehensive Analysis
AI Stock Ranker – Real-Time Fundamental Strength Score
Business Overview and Revenue Trends
Cyient Ltd operates within the IT consulting and software industry, with a current market capitalization of ₹13,040 Cr and a share price of ₹1,174. The company recorded sales of ₹6,016 Cr for the fiscal year ending March 2023, marking a significant increase from ₹4,534 Cr in FY 2022. The revenue trend shows a consistent upward trajectory, with quarterly sales reaching ₹1,778 Cr in September 2023 and projected to rise to ₹1,861 Cr by March 2024. This growth can be attributed to Cyient’s robust service offerings and strategic client engagements across various sectors. The operating profit margin (OPM) stood at 12% for the latest fiscal year, reflecting operational efficiency amidst rising revenues. Cyient’s ability to maintain a healthy sales growth trajectory, alongside an expanding client base, positions it favorably in a competitive landscape marked by digital transformation initiatives across industries.
Profitability and Efficiency Metrics
Cyient’s profitability metrics reveal a mixed performance, with net profit for FY 2023 reported at ₹514 Cr, a decline from ₹522 Cr in FY 2022. However, net profit margin remained relatively stable at 8.55%. The company reported an interest coverage ratio (ICR) of 13.36x, indicating strong capacity to meet interest obligations, which is significantly higher than the typical sector range. Return on equity (ROE) was recorded at 12.8%, while return on capital employed (ROCE) stood at 16.6%, demonstrating effective utilization of capital. Operating profit for the latest fiscal year was ₹1,003 Cr, with an OPM of 17%, showing Cyient’s ability to manage costs effectively despite fluctuating demand. These profitability metrics, combined with efficient expense management, highlight Cyient’s resilience in navigating economic challenges while maintaining profitability.
Balance Sheet Strength and Financial Ratios
Cyient’s balance sheet reflects a solid financial position with total assets amounting to ₹7,621 Cr as of March 2025. The company’s reserves increased to ₹5,254 Cr, up from ₹3,061 Cr in FY 2022, showcasing a healthy retention of earnings. The total borrowing stood at ₹513 Cr, indicating low leverage and a debt-to-equity ratio of 0.04x, which is below typical industry standards, suggesting prudent financial management. The current ratio reported at 3.03x indicates strong liquidity, well above the industry average, ensuring that Cyient can comfortably meet its short-term obligations. Additionally, the price-to-book value (P/BV) ratio of 2.64x suggests that the stock is reasonably valued compared to its net asset value, providing a favorable outlook for investors seeking stability and growth potential in the IT consulting sector.
Shareholding Pattern and Investor Confidence
The shareholding structure of Cyient Ltd shows a diverse investor base, with promoters holding 23.28% of the shares, while foreign institutional investors (FIIs) and domestic institutional investors (DIIs) hold 17.56% and 38.42%, respectively. The public shareholding stands at 20.11%, reflecting a balanced ownership distribution that can enhance corporate governance. Notably, the proportion of FII investment has declined from 31.07% in December 2022 to 17.56% by September 2025, indicating a potential shift in investor sentiment. Conversely, DII ownership has increased, suggesting growing confidence among domestic institutions in Cyient’s long-term prospects. The number of shareholders has also risen to 2,12,929, indicating increasing retail interest. This diverse ownership structure, combined with a strong institutional presence, underscores investor confidence in the company’s strategic direction and operational performance.
Outlook, Risks, and Final Insight
Looking ahead, Cyient is well-positioned to leverage growth opportunities in the IT consulting space, driven by increasing demand for digital transformation solutions. However, potential risks include fluctuations in global economic conditions and competition from larger players in the industry. The ability to maintain operational efficiency while investing in new technologies will be crucial for sustaining growth. Additionally, the declining trend in FII participation may impact stock performance if not addressed. Overall, Cyient’s strong fundamentals, including a solid balance sheet, efficient operations, and a growing institutional investor base, provide a robust foundation for future growth, while remaining vigilant against market uncertainties will be essential for navigating challenges ahead.
Source: Getaka Fundamental Analysis | Generated using proprietary financial data.
Competitors
| Stock Name ⇩ | Market Cap ⇩ | Current Price ⇩ | High / Low ⇩ | Stock P/E ⇩ | Book Value ⇩ | Dividend Yield ⇩ | ROCE ⇩ | ROE ⇩ | Face Value ⇩ |
|---|---|---|---|---|---|---|---|---|---|
| Visesh Infotecnics Ltd | 125 Cr. | 0.33 | / | 1.11 | 0.00 % | 2.21 % | 2.23 % | 1.00 | |
| Mudunuru Ltd | 66.5 Cr. | 21.0 | 21.0/4.43 | 0.20 | 0.00 % | 27.0 % | 90.7 % | 2.00 | |
| Naapbooks Ltd | 131 Cr. | 122 | 194/99.8 | 20.1 | 36.4 | 0.00 % | 23.6 % | 17.1 % | 10.0 |
| IB Infotech Enterprises Ltd | 37.9 Cr. | 296 | 314/140 | 27.1 | 26.7 | 0.34 % | 38.5 % | 35.4 % | 10.0 |
| Hit Kit Global Solutions Ltd | 5.64 Cr. | 1.05 | 1.73/0.91 | 2.47 | 0.00 % | 2.14 % | 2.15 % | 2.00 | |
| Industry Average | 20,383.18 Cr | 540.19 | 83.83 | 123.78 | 0.56% | 14.88% | 20.92% | 6.84 |
Quarterly Result
| Metric | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 1,396 | 1,618 | 1,751 | 1,686 | 1,778 | 1,821 | 1,861 | 1,676 | 1,849 | 1,926 | 1,909 | 1,712 | 1,781 |
| Expenses | 1,192 | 1,335 | 1,429 | 1,371 | 1,453 | 1,495 | 1,526 | 1,411 | 1,552 | 1,648 | 1,611 | 1,484 | 1,567 |
| Operating Profit | 205 | 283 | 322 | 316 | 326 | 326 | 335 | 265 | 297 | 278 | 298 | 228 | 214 |
| OPM % | 15% | 18% | 18% | 19% | 18% | 18% | 18% | 16% | 16% | 14% | 16% | 13% | 12% |
| Other Income | -2 | 19 | -16 | -1 | 7 | -32 | 23 | 21 | 51 | -17 | 41 | 70 | 71 |
| Interest | 31 | 26 | 26 | 28 | 27 | 29 | 32 | 26 | 28 | 20 | 19 | 16 | 16 |
| Depreciation | 63 | 70 | 73 | 68 | 66 | 66 | 67 | 66 | 66 | 68 | 68 | 68 | 72 |
| Profit before tax | 108 | 206 | 208 | 219 | 240 | 200 | 259 | 195 | 254 | 174 | 252 | 214 | 197 |
| Tax % | 27% | 24% | 21% | 23% | 24% | 23% | 24% | 24% | 27% | 26% | 26% | 26% | 27% |
| Net Profit | 79 | 156 | 163 | 169 | 184 | 153 | 197 | 148 | 187 | 128 | 186 | 157 | 143 |
| EPS in Rs | 7.16 | 14.12 | 14.76 | 15.20 | 16.10 | 13.28 | 17.06 | 12.97 | 16.14 | 11.02 | 15.35 | 13.85 | 11.48 |
Last Updated: January 2, 2026, 12:35 am
Below is a detailed analysis of the quarterly data for Cyient Ltd based on the most recent figures (Sep 2025) and their trends compared to the previous period:
- For Sales, as of Sep 2025, the value is 1,781.00 Cr.. The value appears strong and on an upward trend. It has increased from 1,712.00 Cr. (Jun 2025) to 1,781.00 Cr., marking an increase of 69.00 Cr..
- For Expenses, as of Sep 2025, the value is 1,567.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 1,484.00 Cr. (Jun 2025) to 1,567.00 Cr., marking an increase of 83.00 Cr..
- For Operating Profit, as of Sep 2025, the value is 214.00 Cr.. The value appears to be declining and may need further review. It has decreased from 228.00 Cr. (Jun 2025) to 214.00 Cr., marking a decrease of 14.00 Cr..
- For OPM %, as of Sep 2025, the value is 12.00%. The value appears to be declining and may need further review. It has decreased from 13.00% (Jun 2025) to 12.00%, marking a decrease of 1.00%.
- For Other Income, as of Sep 2025, the value is 71.00 Cr.. The value appears strong and on an upward trend. It has increased from 70.00 Cr. (Jun 2025) to 71.00 Cr., marking an increase of 1.00 Cr..
- For Interest, as of Sep 2025, the value is 16.00 Cr.. The value remains steady. There is no change compared to the previous period (Jun 2025) which recorded 16.00 Cr..
- For Depreciation, as of Sep 2025, the value is 72.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 68.00 Cr. (Jun 2025) to 72.00 Cr., marking an increase of 4.00 Cr..
- For Profit before tax, as of Sep 2025, the value is 197.00 Cr.. The value appears to be declining and may need further review. It has decreased from 214.00 Cr. (Jun 2025) to 197.00 Cr., marking a decrease of 17.00 Cr..
- For Tax %, as of Sep 2025, the value is 27.00%. The value appears to be increasing, which may not be favorable. It has increased from 26.00% (Jun 2025) to 27.00%, marking an increase of 1.00%.
- For Net Profit, as of Sep 2025, the value is 143.00 Cr.. The value appears to be declining and may need further review. It has decreased from 157.00 Cr. (Jun 2025) to 143.00 Cr., marking a decrease of 14.00 Cr..
- For EPS in Rs, as of Sep 2025, the value is 11.48. The value appears to be declining and may need further review. It has decreased from 13.85 (Jun 2025) to 11.48, marking a decrease of 2.37.
Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.
Profit & Loss - Annual Report
Last Updated: December 15, 2025, 5:28 am
| Metric | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 2,206 | 2,736 | 3,094 | 3,586 | 3,914 | 4,618 | 4,427 | 4,132 | 4,534 | 6,016 | 7,147 | 7,360 | 7,328 |
| Expenses | 1,796 | 2,335 | 2,680 | 3,109 | 3,394 | 3,985 | 3,881 | 3,557 | 3,717 | 5,013 | 5,844 | 6,222 | 6,310 |
| Operating Profit | 410 | 401 | 414 | 477 | 520 | 633 | 546 | 575 | 818 | 1,003 | 1,303 | 1,138 | 1,019 |
| OPM % | 19% | 15% | 13% | 13% | 13% | 14% | 12% | 14% | 18% | 17% | 18% | 15% | 14% |
| Other Income | 17 | 122 | 112 | 79 | 147 | 131 | 158 | 140 | 112 | 35 | -2 | 97 | 165 |
| Interest | 1 | 6 | 16 | 17 | 20 | 33 | 49 | 43 | 39 | 100 | 116 | 93 | 72 |
| Depreciation | 72 | 71 | 89 | 95 | 105 | 111 | 188 | 194 | 192 | 257 | 267 | 267 | 276 |
| Profit before tax | 354 | 446 | 421 | 444 | 541 | 620 | 468 | 477 | 698 | 681 | 918 | 875 | 836 |
| Tax % | 29% | 25% | 24% | 24% | 26% | 23% | 27% | 24% | 25% | 24% | 23% | 26% | |
| Net Profit | 266 | 351 | 320 | 340 | 403 | 477 | 341 | 364 | 522 | 514 | 703 | 648 | 614 |
| EPS in Rs | 23.76 | 31.43 | 28.94 | 30.54 | 36.00 | 42.33 | 31.14 | 33.06 | 47.35 | 46.52 | 61.57 | 55.45 | 51.70 |
| Dividend Payout % | 21% | 25% | 24% | 34% | 36% | 35% | 48% | 51% | 51% | 56% | 49% | 47% |
YoY Net Profit Growth
| Year | 2014-2015 | 2015-2016 | 2016-2017 | 2017-2018 | 2018-2019 | 2019-2020 | 2020-2021 | 2021-2022 | 2022-2023 | 2023-2024 | 2024-2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| YoY Net Profit Growth (%) | 31.95% | -8.83% | 6.25% | 18.53% | 18.36% | -28.51% | 6.74% | 43.41% | -1.53% | 36.77% | -7.82% |
| Change in YoY Net Profit Growth (%) | 0.00% | -40.79% | 15.08% | 12.28% | -0.17% | -46.87% | 35.26% | 36.66% | -44.94% | 38.30% | -44.59% |
Cyient Ltd has shown an inconsistent trend in YoY Net Profit Growth (%) in the last 11 years from 2014-2015 to 2024-2025.
Growth
| Compounded Sales Growth | |
|---|---|
| 10 Years: | 10% |
| 5 Years: | 11% |
| 3 Years: | 18% |
| TTM: | 4% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | 6% |
| 5 Years: | 12% |
| 3 Years: | 5% |
| TTM: | -10% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | 7% |
| 5 Years: | 25% |
| 3 Years: | 12% |
| 1 Year: | -41% |
| Return on Equity | |
|---|---|
| 10 Years: | 16% |
| 5 Years: | 16% |
| 3 Years: | 16% |
| Last Year: | 13% |
Last Updated: September 5, 2025, 2:25 am
Balance Sheet
Last Updated: December 4, 2025, 1:08 am
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Sep 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 56 | 56 | 56 | 56 | 56 | 55 | 55 | 55 | 55 | 55 | 56 | 56 | 56 |
| Reserves | 1,532 | 1,788 | 1,774 | 2,061 | 2,288 | 2,509 | 2,506 | 2,902 | 3,061 | 3,411 | 4,203 | 5,254 | 5,509 |
| Borrowings | 6 | 147 | 214 | 211 | 283 | 368 | 711 | 577 | 573 | 1,218 | 788 | 513 | 436 |
| Other Liabilities | 356 | 582 | 668 | 798 | 773 | 927 | 870 | 940 | 1,072 | 1,815 | 1,883 | 1,798 | 1,922 |
| Total Liabilities | 1,950 | 2,574 | 2,713 | 3,126 | 3,400 | 3,860 | 4,142 | 4,475 | 4,762 | 6,500 | 6,928 | 7,621 | 7,922 |
| Fixed Assets | 337 | 789 | 657 | 751 | 798 | 978 | 1,305 | 1,361 | 1,345 | 2,825 | 2,826 | 2,929 | 3,063 |
| CWIP | 7 | 10 | 10 | 26 | 52 | 104 | 146 | 88 | 13 | 44 | 57 | 79 | 8 |
| Investments | 93 | 101 | 160 | 196 | 143 | 55 | 41 | 34 | 445 | 518 | 436 | 502 | 508 |
| Other Assets | 1,514 | 1,674 | 1,886 | 2,153 | 2,409 | 2,723 | 2,650 | 2,992 | 2,959 | 3,113 | 3,609 | 4,112 | 4,343 |
| Total Assets | 1,950 | 2,574 | 2,713 | 3,126 | 3,400 | 3,860 | 4,142 | 4,475 | 4,762 | 6,500 | 6,928 | 7,621 | 7,922 |
Below is a detailed analysis of the balance sheet data for Cyient Ltd based on the most recent figures (Sep 2025) and their trends compared to the previous period:
- For Equity Capital, as of Sep 2025, the value is 56.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 56.00 Cr..
- For Reserves, as of Sep 2025, the value is 5,509.00 Cr.. The value appears strong and on an upward trend. It has increased from 5,254.00 Cr. (Mar 2025) to 5,509.00 Cr., marking an increase of 255.00 Cr..
- For Borrowings, as of Sep 2025, the value is 436.00 Cr.. The value appears to be improving (decreasing). Additionally, since Reserves exceed Borrowings, this is considered a positive sign. It has decreased from 513.00 Cr. (Mar 2025) to 436.00 Cr., marking a decrease of 77.00 Cr..
- For Other Liabilities, as of Sep 2025, the value is 1,922.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 1,798.00 Cr. (Mar 2025) to 1,922.00 Cr., marking an increase of 124.00 Cr..
- For Total Liabilities, as of Sep 2025, the value is 7,922.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 7,621.00 Cr. (Mar 2025) to 7,922.00 Cr., marking an increase of 301.00 Cr..
- For Fixed Assets, as of Sep 2025, the value is 3,063.00 Cr.. The value appears strong and on an upward trend. It has increased from 2,929.00 Cr. (Mar 2025) to 3,063.00 Cr., marking an increase of 134.00 Cr..
- For CWIP, as of Sep 2025, the value is 8.00 Cr.. The value appears to be declining and may need further review. It has decreased from 79.00 Cr. (Mar 2025) to 8.00 Cr., marking a decrease of 71.00 Cr..
- For Investments, as of Sep 2025, the value is 508.00 Cr.. The value appears strong and on an upward trend. It has increased from 502.00 Cr. (Mar 2025) to 508.00 Cr., marking an increase of 6.00 Cr..
- For Other Assets, as of Sep 2025, the value is 4,343.00 Cr.. The value appears strong and on an upward trend. It has increased from 4,112.00 Cr. (Mar 2025) to 4,343.00 Cr., marking an increase of 231.00 Cr..
- For Total Assets, as of Sep 2025, the value is 7,922.00 Cr.. The value appears strong and on an upward trend. It has increased from 7,621.00 Cr. (Mar 2025) to 7,922.00 Cr., marking an increase of 301.00 Cr..
Notably, the Reserves (5,509.00 Cr.) exceed the Borrowings (436.00 Cr.), indicating a solid financial buffer.
Overall, while many items appear to show a positive trend, any significant downward movement or items where Borrowings exceed Reserves warrant further investigation.
Cash Flow
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Free Cash Flow
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Free Cash Flow | 404.00 | 254.00 | 200.00 | 266.00 | 237.00 | 265.00 | -165.00 | -2.00 | 245.00 | 0.00 | -787.00 | -512.00 |
Free Cash Flow = Income Generated from Operational Activities - Borrowings - Capital Work in Progress (CWIP)
Consistent positive free cash flow is crucial for businesses as it indicates their ability to generate cash from their core operations. It provides financial flexibility, allowing companies to invest in growth opportunities, pay dividends to shareholders, reduce debt, and weather economic downturns more effectively.
Financial Efficiency Indicators
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | 79 | 71 | 72 | 66 | 64 | 64 | 60 | 71 | 59 | 68 | 64 | 70 |
| Inventory Days | 189 | 124 | 156 | 160 | 211 | 110 | 178 | 228 | 177 | 185 | ||
| Days Payable | 599 | 522 | 453 | 323 | 347 | 314 | 336 | 374 | 189 | 126 | ||
| Cash Conversion Cycle | 79 | 71 | -337 | -331 | -233 | -99 | -76 | -133 | -99 | -78 | 52 | 128 |
| Working Capital Days | 65 | 43 | 41 | 27 | 36 | 47 | 35 | 24 | 23 | 17 | 43 | 64 |
| ROCE % | 24% | 25% | 22% | 22% | 23% | 24% | 17% | 15% | 20% | 20% | 22% | 17% |
Mutual Fund Holdings
| Fund Name | No of Shares | AUM (%) | Amount Invested (Cr) | Previous Number of Shares | Previous Date | Percentage Change |
|---|---|---|---|---|---|---|
| HDFC Flexi Cap Fund | 5,500,000 | 0.66 | 617.98 | 5,000,000 | 2025-12-15 01:35:34 | 10% |
| Kotak Small Cap Fund | 3,311,236 | 2.14 | 372.05 | N/A | N/A | N/A |
| DSP Small Cap Fund | 3,000,000 | 1.98 | 337.08 | 3,300,697 | 2025-12-07 00:36:42 | -9.11% |
| Nippon India Small Cap Fund | 2,865,876 | 0.47 | 322.01 | 2,850,983 | 2025-12-15 01:35:34 | 0.52% |
| Tata Digital India Fund | 1,855,043 | 1.72 | 208.43 | N/A | N/A | N/A |
| ICICI Prudential Technology Fund | 1,530,937 | 1.11 | 172.02 | 1,430,937 | 2025-12-15 01:35:34 | 6.99% |
| DSP Mid Cap Fund | 1,418,197 | 0.8 | 159.35 | 2,481,398 | 2025-12-07 00:36:42 | -42.85% |
| Aditya Birla Sun Life Digital India Fund | 1,125,705 | 2.61 | 126.48 | 1,157,301 | 2025-12-15 01:35:34 | -2.73% |
| Bandhan Small Cap Fund | 1,106,084 | 0.68 | 124.28 | 1,094,084 | 2025-12-15 01:35:34 | 1.1% |
| ICICI Prudential Multicap Fund | 1,079,645 | 0.75 | 121.31 | 571,817 | 2025-12-07 00:36:42 | 88.81% |
Key Financial Ratios
| Month | Mar 25 | Mar 24 | Mar 23 | Mar 22 | Mar 21 |
|---|---|---|---|---|---|
| FaceValue | 5.00 | 5.00 | 5.00 | 5.00 | 5.00 |
| Basic EPS (Rs.) | 55.95 | 62.24 | 47.03 | 47.75 | 33.08 |
| Diluted EPS (Rs.) | 55.51 | 61.71 | 46.71 | 47.54 | 33.06 |
| Cash EPS (Rs.) | 82.92 | 87.34 | 69.71 | 64.72 | 50.75 |
| Book Value[Excl.RevalReserv]/Share (Rs.) | 478.32 | 410.53 | 313.16 | 282.01 | 268.49 |
| Book Value[Incl.RevalReserv]/Share (Rs.) | 478.32 | 410.53 | 313.16 | 282.01 | 268.49 |
| Revenue From Operations / Share (Rs.) | 663.10 | 643.89 | 543.93 | 410.72 | 375.67 |
| PBDIT / Share (Rs.) | 111.70 | 123.31 | 98.06 | 84.23 | 64.99 |
| PBIT / Share (Rs.) | 87.63 | 99.28 | 74.86 | 66.82 | 47.31 |
| PBT / Share (Rs.) | 79.27 | 82.74 | 61.59 | 63.26 | 43.37 |
| Net Profit / Share (Rs.) | 58.85 | 63.31 | 46.51 | 47.31 | 33.07 |
| NP After MI And SOA / Share (Rs.) | 55.47 | 61.51 | 46.51 | 47.31 | 33.07 |
| PBDIT Margin (%) | 16.84 | 19.15 | 18.02 | 20.50 | 17.29 |
| PBIT Margin (%) | 13.21 | 15.41 | 13.76 | 16.26 | 12.59 |
| PBT Margin (%) | 11.95 | 12.84 | 11.32 | 15.40 | 11.54 |
| Net Profit Margin (%) | 8.87 | 9.83 | 8.55 | 11.51 | 8.80 |
| NP After MI And SOA Margin (%) | 8.36 | 9.55 | 8.55 | 11.51 | 8.80 |
| Return on Networth / Equity (%) | 11.59 | 16.03 | 14.83 | 16.75 | 12.30 |
| Return on Capital Employeed (%) | 15.37 | 20.61 | 18.29 | 20.92 | 15.37 |
| Return On Assets (%) | 8.00 | 9.74 | 7.85 | 10.91 | 8.09 |
| Long Term Debt / Equity (X) | 0.01 | 0.06 | 0.14 | 0.00 | 0.01 |
| Total Debt / Equity (X) | 0.04 | 0.10 | 0.26 | 0.10 | 0.09 |
| Asset Turnover Ratio (%) | 1.00 | 1.05 | 0.54 | 0.45 | 0.38 |
| Current Ratio (X) | 3.03 | 2.15 | 1.58 | 2.30 | 2.57 |
| Quick Ratio (X) | 2.60 | 1.86 | 1.36 | 2.07 | 2.43 |
| Inventory Turnover Ratio (X) | 2.18 | 2.19 | 0.00 | 0.00 | 0.00 |
| Dividend Payout Ratio (NP) (%) | 53.59 | 44.81 | 51.20 | 56.51 | 0.00 |
| Dividend Payout Ratio (CP) (%) | 37.37 | 32.22 | 34.16 | 41.31 | 0.00 |
| Earning Retention Ratio (%) | 46.41 | 55.19 | 48.80 | 43.49 | 0.00 |
| Cash Earning Retention Ratio (%) | 62.63 | 67.78 | 65.84 | 58.69 | 0.00 |
| Interest Coverage Ratio (X) | 13.36 | 11.80 | 10.85 | 23.66 | 16.51 |
| Interest Coverage Ratio (Post Tax) (X) | 8.04 | 7.64 | 6.61 | 14.29 | 9.40 |
| Enterprise Value (Cr.) | 13380.90 | 21896.86 | 11188.05 | 9314.42 | 5941.90 |
| EV / Net Operating Revenue (X) | 1.82 | 3.06 | 1.86 | 2.05 | 1.44 |
| EV / EBITDA (X) | 10.79 | 16.00 | 10.32 | 10.02 | 8.31 |
| MarketCap / Net Operating Revenue (X) | 1.91 | 3.10 | 1.82 | 2.26 | 1.73 |
| Retention Ratios (%) | 46.40 | 55.18 | 48.79 | 43.48 | 0.00 |
| Price / BV (X) | 2.64 | 5.20 | 3.17 | 3.29 | 2.41 |
| Price / Net Operating Revenue (X) | 1.91 | 3.10 | 1.82 | 2.26 | 1.73 |
| EarningsYield | 0.04 | 0.03 | 0.04 | 0.05 | 0.05 |
After reviewing the key financial ratios for Cyient Ltd, here is a detailed analysis based on the latest available data and recent trends:
- For FaceValue, as of Mar 25, the value is 5.00. This value is within the healthy range. There is no change compared to the previous period (Mar 24) which recorded 5.00.
- For Basic EPS (Rs.), as of Mar 25, the value is 55.95. This value is within the healthy range. It has decreased from 62.24 (Mar 24) to 55.95, marking a decrease of 6.29.
- For Diluted EPS (Rs.), as of Mar 25, the value is 55.51. This value is within the healthy range. It has decreased from 61.71 (Mar 24) to 55.51, marking a decrease of 6.20.
- For Cash EPS (Rs.), as of Mar 25, the value is 82.92. This value is within the healthy range. It has decreased from 87.34 (Mar 24) to 82.92, marking a decrease of 4.42.
- For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 478.32. It has increased from 410.53 (Mar 24) to 478.32, marking an increase of 67.79.
- For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 478.32. It has increased from 410.53 (Mar 24) to 478.32, marking an increase of 67.79.
- For Revenue From Operations / Share (Rs.), as of Mar 25, the value is 663.10. It has increased from 643.89 (Mar 24) to 663.10, marking an increase of 19.21.
- For PBDIT / Share (Rs.), as of Mar 25, the value is 111.70. This value is within the healthy range. It has decreased from 123.31 (Mar 24) to 111.70, marking a decrease of 11.61.
- For PBIT / Share (Rs.), as of Mar 25, the value is 87.63. This value is within the healthy range. It has decreased from 99.28 (Mar 24) to 87.63, marking a decrease of 11.65.
- For PBT / Share (Rs.), as of Mar 25, the value is 79.27. This value is within the healthy range. It has decreased from 82.74 (Mar 24) to 79.27, marking a decrease of 3.47.
- For Net Profit / Share (Rs.), as of Mar 25, the value is 58.85. This value is within the healthy range. It has decreased from 63.31 (Mar 24) to 58.85, marking a decrease of 4.46.
- For NP After MI And SOA / Share (Rs.), as of Mar 25, the value is 55.47. This value is within the healthy range. It has decreased from 61.51 (Mar 24) to 55.47, marking a decrease of 6.04.
- For PBDIT Margin (%), as of Mar 25, the value is 16.84. This value is within the healthy range. It has decreased from 19.15 (Mar 24) to 16.84, marking a decrease of 2.31.
- For PBIT Margin (%), as of Mar 25, the value is 13.21. This value is within the healthy range. It has decreased from 15.41 (Mar 24) to 13.21, marking a decrease of 2.20.
- For PBT Margin (%), as of Mar 25, the value is 11.95. This value is within the healthy range. It has decreased from 12.84 (Mar 24) to 11.95, marking a decrease of 0.89.
- For Net Profit Margin (%), as of Mar 25, the value is 8.87. This value is within the healthy range. It has decreased from 9.83 (Mar 24) to 8.87, marking a decrease of 0.96.
- For NP After MI And SOA Margin (%), as of Mar 25, the value is 8.36. This value is within the healthy range. It has decreased from 9.55 (Mar 24) to 8.36, marking a decrease of 1.19.
- For Return on Networth / Equity (%), as of Mar 25, the value is 11.59. This value is below the healthy minimum of 15. It has decreased from 16.03 (Mar 24) to 11.59, marking a decrease of 4.44.
- For Return on Capital Employeed (%), as of Mar 25, the value is 15.37. This value is within the healthy range. It has decreased from 20.61 (Mar 24) to 15.37, marking a decrease of 5.24.
- For Return On Assets (%), as of Mar 25, the value is 8.00. This value is within the healthy range. It has decreased from 9.74 (Mar 24) to 8.00, marking a decrease of 1.74.
- For Long Term Debt / Equity (X), as of Mar 25, the value is 0.01. This value is below the healthy minimum of 0.2. It has decreased from 0.06 (Mar 24) to 0.01, marking a decrease of 0.05.
- For Total Debt / Equity (X), as of Mar 25, the value is 0.04. This value is within the healthy range. It has decreased from 0.10 (Mar 24) to 0.04, marking a decrease of 0.06.
- For Asset Turnover Ratio (%), as of Mar 25, the value is 1.00. It has decreased from 1.05 (Mar 24) to 1.00, marking a decrease of 0.05.
- For Current Ratio (X), as of Mar 25, the value is 3.03. This value exceeds the healthy maximum of 3. It has increased from 2.15 (Mar 24) to 3.03, marking an increase of 0.88.
- For Quick Ratio (X), as of Mar 25, the value is 2.60. This value exceeds the healthy maximum of 2. It has increased from 1.86 (Mar 24) to 2.60, marking an increase of 0.74.
- For Inventory Turnover Ratio (X), as of Mar 25, the value is 2.18. This value is below the healthy minimum of 4. It has decreased from 2.19 (Mar 24) to 2.18, marking a decrease of 0.01.
- For Dividend Payout Ratio (NP) (%), as of Mar 25, the value is 53.59. This value exceeds the healthy maximum of 50. It has increased from 44.81 (Mar 24) to 53.59, marking an increase of 8.78.
- For Dividend Payout Ratio (CP) (%), as of Mar 25, the value is 37.37. This value is within the healthy range. It has increased from 32.22 (Mar 24) to 37.37, marking an increase of 5.15.
- For Earning Retention Ratio (%), as of Mar 25, the value is 46.41. This value is within the healthy range. It has decreased from 55.19 (Mar 24) to 46.41, marking a decrease of 8.78.
- For Cash Earning Retention Ratio (%), as of Mar 25, the value is 62.63. This value is within the healthy range. It has decreased from 67.78 (Mar 24) to 62.63, marking a decrease of 5.15.
- For Interest Coverage Ratio (X), as of Mar 25, the value is 13.36. This value is within the healthy range. It has increased from 11.80 (Mar 24) to 13.36, marking an increase of 1.56.
- For Interest Coverage Ratio (Post Tax) (X), as of Mar 25, the value is 8.04. This value is within the healthy range. It has increased from 7.64 (Mar 24) to 8.04, marking an increase of 0.40.
- For Enterprise Value (Cr.), as of Mar 25, the value is 13,380.90. It has decreased from 21,896.86 (Mar 24) to 13,380.90, marking a decrease of 8,515.96.
- For EV / Net Operating Revenue (X), as of Mar 25, the value is 1.82. This value is within the healthy range. It has decreased from 3.06 (Mar 24) to 1.82, marking a decrease of 1.24.
- For EV / EBITDA (X), as of Mar 25, the value is 10.79. This value is within the healthy range. It has decreased from 16.00 (Mar 24) to 10.79, marking a decrease of 5.21.
- For MarketCap / Net Operating Revenue (X), as of Mar 25, the value is 1.91. This value is within the healthy range. It has decreased from 3.10 (Mar 24) to 1.91, marking a decrease of 1.19.
- For Retention Ratios (%), as of Mar 25, the value is 46.40. This value is within the healthy range. It has decreased from 55.18 (Mar 24) to 46.40, marking a decrease of 8.78.
- For Price / BV (X), as of Mar 25, the value is 2.64. This value is within the healthy range. It has decreased from 5.20 (Mar 24) to 2.64, marking a decrease of 2.56.
- For Price / Net Operating Revenue (X), as of Mar 25, the value is 1.91. This value is within the healthy range. It has decreased from 3.10 (Mar 24) to 1.91, marking a decrease of 1.19.
- For EarningsYield, as of Mar 25, the value is 0.04. This value is below the healthy minimum of 5. It has increased from 0.03 (Mar 24) to 0.04, marking an increase of 0.01.
Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.
Strength and Weakness
| Strength | Weakness |
|---|---|
|
|
Stock Analysis
- Considering all of the following key financial indicators, prospective investors are encouraged to conduct thorough research and seek professional guidance before considering any investment in Cyient Ltd:
- Net Profit Margin: 8.87%
- Net Profit Margin: This metric indicates the percentage of profit a company makes from its total revenue. A higher net profit margin is generally desirable as it reflects better profitability.
- ROCE: 15.37% (Industry Average ROCE: 14.88%)
- ROCE (Return on Capital Employed): ROCE measures a company's profitability and the efficiency with which its capital is employed. A higher ROCE indicates efficient use of capital.
- ROE%: 11.59% (Industry Average ROE: 20.92%)
- ROE (Return on Equity): ROE measures a company's profitability relative to shareholders' equity. A higher ROE indicates efficient use of shareholders' funds.
- Interest Coverage Ratio (Post Tax): 8.04
- Interest Coverage Ratio: The interest coverage ratio measures a company's ability to cover its interest payments on outstanding debt. A ratio greater than 2 is generally considered healthy as it indicates the company can meet its interest obligations comfortably.
- Quick Ratio: 2.6
- Quick Ratio: The quick ratio assesses a company's ability to cover its short-term liabilities with its most liquid assets. A ratio higher than 1 suggests the company can meet its short-term obligations without relying heavily on inventory.
- Stock P/E: 23.2 (Industry average Stock P/E: 83.83)
- Stock P/E (Price-to-Earnings) Ratio: The P/E ratio compares a company's current share price to its earnings per share. A lower P/E ratio relative to industry peers or historical values may indicate that the stock is undervalued.
- Total Debt / Equity: 0.04
- Total Debt / Equity: This ratio measures a company's financial leverage by comparing its total debt to its total equity. A lower ratio indicates lower financial risk and greater financial stability.
Stock Rating: - Net Profit Margin: 8.87%
About the Company - Qualitative Analysis
| INDUSTRY | ADDRESS | CONTACT |
|---|---|---|
| IT Consulting & Software | 4th Floor, �A� Wing, Hyderabad Telangana 500081 | Contact not found |
| Management | |
|---|---|
| Name | Position Held |
| Mr. B V R Mohan Reddy | Founder Chairman |
| Mr. M M Murugappan | Non Executive Chairman |
| Mr. Krishna Bodanapu | Exec. Vice Chairman & Mang Dir |
| Mr. Sukamal Banerjee | Executive Director & CEO |
| Mr. Nitin Prasad | Independent Director |
| Ms. Matangi Gowrishankar | Independent Director |
| Mr. Vikas Sehgal | Independent Director |
| Mr. Vivek Narayan Gouir | Independent Director |
| Ms. Debjani Ghosh | Independent Director |
FAQ
What is the intrinsic value of Cyient Ltd?
Cyient Ltd's intrinsic value (as of 14 January 2026) is ₹1216.52 which is 3.45% higher the current market price of ₹1,176.00, indicating undervalued. Calculated using the PE ratio method, this valuation considers the company's ₹13,065 Cr. market cap, FY2025-2026 high/low of ₹1,808/1,050, reserves of ₹5,509 Cr, and liabilities of ₹7,922 Cr.
What is the Market Cap of Cyient Ltd?
The Market Cap of Cyient Ltd is 13,065 Cr..
What is the current Stock Price of Cyient Ltd as on 14 January 2026?
The current stock price of Cyient Ltd as on 14 January 2026 is ₹1,176.
What is the High / Low of Cyient Ltd stocks in FY 2025-2026?
In FY 2025-2026, the High / Low of Cyient Ltd stocks is ₹1,808/1,050.
What is the Stock P/E of Cyient Ltd?
The Stock P/E of Cyient Ltd is 23.2.
What is the Book Value of Cyient Ltd?
The Book Value of Cyient Ltd is 501.
What is the Dividend Yield of Cyient Ltd?
The Dividend Yield of Cyient Ltd is 2.21 %.
What is the ROCE of Cyient Ltd?
The ROCE of Cyient Ltd is 16.6 %.
What is the ROE of Cyient Ltd?
The ROE of Cyient Ltd is 12.8 %.
What is the Face Value of Cyient Ltd?
The Face Value of Cyient Ltd is 5.00.